The Subject-by-Formulation Interaction as a Criterion of Interchangeability of Drugs

DOI10.2307/2531776zbMath0718.62228OpenAlexW2314775687MaRDI QIDQ5750260

Hans Melander, Gunnar Ekbohm

Publication date: 1989

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2307/2531776

zbMATH Keywords

interchangeabilitysubject-by-formulation interactionbioequivalence trials

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items

Unit–Treatment Interaction and Its Practical Consequences, Subject-treatment interactions in crossover trials: performance evaluation of subgrouping methods, Analysis of multiple-dose bioequivalence studies, Individual bioequivalence—a regulatory update, Discussion of individual bioequivalence by M.-L. chen, Individual bioequivalence—a european perspective, Some thoughts on individual bioequivalence